Skip to main content
Clinical Trials/CTRI/2020/02/023430
CTRI/2020/02/023430Not yet recruitingPhase 4

A Comparative study to evaluate the Hypoglycaemic Effect of Haridra Churna and Chandraprabha Vati in Madhumeha (Type-2 Diabetes Mellitus)

Department of Kayachikitsa Ch Brahm Prakash Ayurved Charak Sansthan0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients with age between 40-60yrs.
  • 2. Sex: Both male and female
  • 3. Patients fulfilling the diagnostic criteria for Diabetes Mellitus framed by the AMERICAN DIABETES ASSOCIATION.
  • 4. FBS-126-200mg/dl PPBS-150-350mg/dl
  • 5.HbA1c 7% and more
  • 6.Patients taking any type of oral anti-diabetic treatment from 1. Biguanides and 2. Sulfonylurea
  • 1. Patients with age between 40-60yrs.
  • 2. Sex: Both male and female
  • 3. Patients fulfilling the diagnostic criteria for Diabetes Mellitus framed by the AMERICAN DIABETES ASSOCIATION.
  • 4. FBS-126-200mg/dl PPBS-150-350mg/dl
  • 5. HbA1c 7% and more
  • 6. Patients taking any type of oral anti-diabetic treatment from 1. Biguanides and 2. Sulfonylurea

Exclusion Criteria

  • 1. Patients below the age of 40 years and more than the age of 60 years
  • 2. Fasting Blood Sugar Level <126 mg/dl and >200 mg/dl
  • Post Prandial Blood Sugar Level <180 mg/dl and >350 mg/dl
  • 3. HbA1c <7%.
  • 4. Patients depending on the insulin for blood glucose control.
  • 5. Patients with diabetic complications.
  • 6. Patients suffering from Secondary Diabetes.
  • 7. Gestational diabetes.
  • 8. Pregnant ladies and lactating mothers.

Investigators

Sponsor
Department of Kayachikitsa Ch Brahm Prakash Ayurved Charak Sansthan

Similar Trials

Effect Of Haridra Churna (Haldi) in... | Clinical Trial